Immuno-oncology company Affimed to be delisted from Nasdaq after insolvency filing (AFMD:NASDAQ) – Seeking Alpha
Immuno-oncology company Affimed to be delisted from Nasdaq after insolvency filing (AFMD:NASDAQ) Seeking Alpha Read the original article here